On the Record · Qiagen
Qiagen competitors, on the record
The companies whose own annual reports name Qiagen as a competitor, each with the sentence it appears in and the filing it came from.
Who Qiagen names
Qiagen’s annual reports for 2023 to 2025 describe its competition by kind of business and do not name competing companies.
Who names Qiagen
Companies whose own annual reports name Qiagen as a competitor.
Word for word“Some of our principal competitors include, among others, Abbott Laboratories, bioMérieux, Bio-Rad, Danaher, Diasorin, Hologic, Qiagen, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Waters Corporation (acquired BD Diagnostics division) and Wermerson Immuncor.” 10-K for 2025
Read from Qiagen’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-03-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.